Unitas Pharma OÜ
RegisteredKey figures
Ratios
2025Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Summary: Unitas Pharma OÜ
What kind of company is it?
Unitas Pharma OÜ (registry code 12218170) is a private limited company (OÜ). The company was entered in the Commercial Register in 2012 and has been registered for 14 years. Registered location: Haabersti linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is retail sale of medical and orthopaedic goods (EMTAK 47741). The company is registered for VAT (VAT number EE101534019).
How is the company doing financially?
Revenue in financial year 2025 was 405 997 €, down 12,0% on the previous year (461 281 €). From 2019 to 2025, revenue grew by an average of 10,6% per year. Net profit for financial year 2025 was 50 617 € (12,5% of revenue). The company was profitable in all 7 published financial years. According to the report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 691 390 € and equity 673 077 € (97,4% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, turnover in Q3 2026 was 97 144 €, down 15,2% on the same quarter a year earlier. Labour taxes paid in the quarter: 1866 €.
Who runs the company and who owns it?
The company has one management board member. The sole owner of the company is a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 29.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. The LEI code (485100RM8LLRMMY3EO26) comes from the GLEIF database. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 97 144 € | — | 1866 € |
| Q2 2026 | 155 792 € | — | 1866 € |
| Q1 2026 | 168 395 € | — | 1244 € |
| Q4 2025 | 126 775 € | — | 0 € |
| Q3 2025 | 114 598 € | — | 0 € |
| Q2 2025 | 146 134 € | — | 0 € |
| Q1 2025 | 177 391 € | — | 0 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculatedNo dividends were distributed.
Summary of financial statements2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 362 415 | 415 081 | 379 628 | 461 281 | 405 997 |
| Net profit | 57 811 | 128 603 | 111 851 | 180 833 | 50 617 |
| Retained earnings | 143 363 | 201 174 | 329 777 | 441 628 | 622 460 |
| Total assets | 223 974 | 335 060 | 465 455 | 639 538 | 691 390 |
| Total liabilities | 20 300 | 5283 | 23 827 | 17 077 | 18 313 |
| Total equity | 203 674 | 329 777 | 441 628 | 622 461 | 673 077 |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Selver AS622 m €
- ORLEN Eesti OÜ609 m €
- AS Alexela555 m €
- Coop Eesti Keskühistu549 m €
- aktsiaselts Olerex543 m €